Top Markets
Coin of the day
Noxopharm Limited Noxopharm Limited

Noxopharm Limited

NOX
주식 순위 #17276
Noxopharm Limited, a drug development company, focuses on developing treatment... Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate cancer and other solid tumors; LuPIN with combined therapy of Veyonda and 177Lu-PSMA-617 for the treatment of late-stage prostate cancer; IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types; and chemotherapy enhancement program (CEP) combined with carboplatin for patients with refractory solid tumors in the breast, head and neck, lung, prostate, and ovaries. In addition, it develops NOXCOVID Program, a dose escalation and dose expansion study of NOX66 for the treatment of COVID-19 infection. Further, the company develops programs to treat pancreatic cancer and glioblastoma. Noxopharm Limited has a collaboration with Hudson Institute of Medical Research and The Australian National University for the research and development of therapeutic drug against inflammatory disorders. The company was incorporated in 2015 and is based in Chatswood, Australia.
주가
$0.0416118
시가총액
$12.78M
변동 (1일)
1.72%
변동 (1년)
-22.01%
국가
AU
거래 Noxopharm Limited (NOX)

카테고리

Noxopharm Limited (NOX)의 영업이익률
March 2026 기준 영업이익률 TTM: -532.32%
Noxopharm Limited의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 -532.32%입니다. 2024년 말 기준 영업이익률은 -313.92%였습니다.
Noxopharm Limited의 영업이익률 기록 (2016 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
2026 (TTM) -532.32% 55.59%
2025 -342.14% 8.99%
2024 -313.92% 13.69%
2023 -276.12% -1.43%
2022 -280.14% 7.54%
2021 -260.50% 31.83%
2020 -197.61% -52.69%
2019 -417.69% -63.54%
2018 -1,145.69% -55.34%
2017 -2,565.11% 0.00%
2016 0.00% 0.00%
유사 기업 또는 경쟁사의 영업이익률
회사 영업이익률 영업이익률 차이 국가
41.30% -100.08%
DK
35.45% -100.07%
US
24.95% -100.05%
US
25.32% -100.05%
BE
25.72% -100.05%
AU
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.